Researchers are looking at the potential of a technique called differential target multiplexed programming (DTMP) to reduce chronic pain by targeting certain proteins linked to inflammation.
In a study of cancer patients treated with methylnaltrexone, about 50%–70% experienced relief from opioid-induced constipation within 4 hours without the use of additional treatments, compared with 15% of placebo-treated patients. In addition, more patients treated with methylnaltrexone maintained a response at 24 hours after dosing compared with patients treated with placebo.
A recent study conducted by physicians across the country shows promise for a new treatment option for patients suffering chronic pain from diabetic neuropathy. The treatment entails spinal cord stimulator implantation, a technique commonly associated with chronic back and leg pain treatment.